Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria
Abstract Background As part of implementation quality standards, community distributors are expected to ensure that only age-eligible children (aged 3–59 months) receive seasonal malaria chemoprevention (SMC) medicines during monthly campaigns. There is uncertainty about the extent to which SMC medi...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-03-01
|
| Series: | Malaria Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12936-024-04916-z |
| _version_ | 1797233769899360256 |
|---|---|
| author | Taiwo Ibinaiye Kunle Rotimi Ayodeji Balogun Adaeze Aidenagbon Chibuzo Oguoma Christian Rassi Kevin Baker Olusola Oresanya Chuks Nnaji |
| author_facet | Taiwo Ibinaiye Kunle Rotimi Ayodeji Balogun Adaeze Aidenagbon Chibuzo Oguoma Christian Rassi Kevin Baker Olusola Oresanya Chuks Nnaji |
| author_sort | Taiwo Ibinaiye |
| collection | DOAJ |
| description | Abstract Background As part of implementation quality standards, community distributors are expected to ensure that only age-eligible children (aged 3–59 months) receive seasonal malaria chemoprevention (SMC) medicines during monthly campaigns. There is uncertainty about the extent to which SMC medicines are administered to ineligible children. This study aimed to assess the magnitude of this occurrence, while exploring the factors associated with it across nine states where SMC was delivered in Nigeria during the 2022 round. Methods This analysis was based on data from representative end-of-round SMC household surveys conducted in nine SMC-implementing states in Nigeria. Data of 3299 age-ineligible children aged > 5 years and their caregivers were extracted from the survey dataset. Prevalence of receipt of SMC medicines by ineligible children was described by child-, caregiver- and SMC-related factors. Mixed-effects multivariable logistic regression models were fitted to explore the factors associated with ineligible receipt of SMC medicines. Results 30.30% (95% CI 27.80–32.90) of ineligible children sampled received at least one dose of SMC medicines in 2022, the majority (60.60%) of whom were aged 5–6 years while the rest were aged 7–10 years. There were lower odds of an age-ineligible child receiving SMC among caregivers who had knowledge of SMC age eligibility (OR: 0.53, 95% CI 0.37–0.77, p < 0.001), compared with those who were knowledgeable of age eligibility. Higher odds of receipt of SMC were found among age-ineligible children whose caregivers had higher confidence in the protective effect of SMC against malaria (OR: 2.01, 95% CI 1.07–3.72, p = 0.030), compared with those whose caregivers were less confident. Compared with ineligible children of younger caregivers (aged < 20 years), those whose caregivers were older had lower odds of receiving SMC than those whose caregivers were younger; with lower odds among children of caregivers aged 20–39 years (OR: 0.50, 95% CI 0.30–0.82, p = 0.006). Conclusions This study contributes important evidence on the magnitude of the receipt of SMC medicines by age-ineligible children, while identifying individual and contextual factors associated with it. The findings provide potentially useful insights that can help inform and guide context-specific SMC implementation quality improvement efforts. |
| first_indexed | 2024-04-24T16:21:26Z |
| format | Article |
| id | doaj.art-a688c5191d2e471fa0bec11d732c1fb1 |
| institution | Directory Open Access Journal |
| issn | 1475-2875 |
| language | English |
| last_indexed | 2024-04-24T16:21:26Z |
| publishDate | 2024-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Malaria Journal |
| spelling | doaj.art-a688c5191d2e471fa0bec11d732c1fb12024-03-31T11:11:15ZengBMCMalaria Journal1475-28752024-03-012311910.1186/s12936-024-04916-zReceipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in NigeriaTaiwo Ibinaiye0Kunle Rotimi1Ayodeji Balogun2Adaeze Aidenagbon3Chibuzo Oguoma4Christian Rassi5Kevin Baker6Olusola Oresanya7Chuks Nnaji8Malaria ConsortiumMalaria ConsortiumMalaria ConsortiumMalaria ConsortiumMalaria ConsortiumMalaria Consortium, The Green HouseMalaria Consortium, The Green HouseMalaria ConsortiumMalaria Consortium, The Green HouseAbstract Background As part of implementation quality standards, community distributors are expected to ensure that only age-eligible children (aged 3–59 months) receive seasonal malaria chemoprevention (SMC) medicines during monthly campaigns. There is uncertainty about the extent to which SMC medicines are administered to ineligible children. This study aimed to assess the magnitude of this occurrence, while exploring the factors associated with it across nine states where SMC was delivered in Nigeria during the 2022 round. Methods This analysis was based on data from representative end-of-round SMC household surveys conducted in nine SMC-implementing states in Nigeria. Data of 3299 age-ineligible children aged > 5 years and their caregivers were extracted from the survey dataset. Prevalence of receipt of SMC medicines by ineligible children was described by child-, caregiver- and SMC-related factors. Mixed-effects multivariable logistic regression models were fitted to explore the factors associated with ineligible receipt of SMC medicines. Results 30.30% (95% CI 27.80–32.90) of ineligible children sampled received at least one dose of SMC medicines in 2022, the majority (60.60%) of whom were aged 5–6 years while the rest were aged 7–10 years. There were lower odds of an age-ineligible child receiving SMC among caregivers who had knowledge of SMC age eligibility (OR: 0.53, 95% CI 0.37–0.77, p < 0.001), compared with those who were knowledgeable of age eligibility. Higher odds of receipt of SMC were found among age-ineligible children whose caregivers had higher confidence in the protective effect of SMC against malaria (OR: 2.01, 95% CI 1.07–3.72, p = 0.030), compared with those whose caregivers were less confident. Compared with ineligible children of younger caregivers (aged < 20 years), those whose caregivers were older had lower odds of receiving SMC than those whose caregivers were younger; with lower odds among children of caregivers aged 20–39 years (OR: 0.50, 95% CI 0.30–0.82, p = 0.006). Conclusions This study contributes important evidence on the magnitude of the receipt of SMC medicines by age-ineligible children, while identifying individual and contextual factors associated with it. The findings provide potentially useful insights that can help inform and guide context-specific SMC implementation quality improvement efforts.https://doi.org/10.1186/s12936-024-04916-zMalariaSeasonal malaria chemopreventionCoverageEligibilityProgramme improvement |
| spellingShingle | Taiwo Ibinaiye Kunle Rotimi Ayodeji Balogun Adaeze Aidenagbon Chibuzo Oguoma Christian Rassi Kevin Baker Olusola Oresanya Chuks Nnaji Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria Malaria Journal Malaria Seasonal malaria chemoprevention Coverage Eligibility Programme improvement |
| title | Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria |
| title_full | Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria |
| title_fullStr | Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria |
| title_full_unstemmed | Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria |
| title_short | Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria |
| title_sort | receipt of seasonal malaria chemoprevention by age ineligible children and associated factors in nine implementation states in nigeria |
| topic | Malaria Seasonal malaria chemoprevention Coverage Eligibility Programme improvement |
| url | https://doi.org/10.1186/s12936-024-04916-z |
| work_keys_str_mv | AT taiwoibinaiye receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria AT kunlerotimi receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria AT ayodejibalogun receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria AT adaezeaidenagbon receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria AT chibuzooguoma receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria AT christianrassi receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria AT kevinbaker receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria AT olusolaoresanya receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria AT chuksnnaji receiptofseasonalmalariachemopreventionbyageineligiblechildrenandassociatedfactorsinnineimplementationstatesinnigeria |